Home > Financial Ratios > LINCOLN PHARMACEUTICALS

LINCOLN PHARMACEUTICALS
Fixed Capital/Sales

    Back to All Ratios
LINCOLN PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for LINCOLN PHARMACEUTICALS
Please provide your vote to see the results

LINCOLN PHARMACEUTICALS Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Fixed Capital/Sales(x) 0.380.370.360.340.32

What is the latest Fixed Capital/Sales ratio of LINCOLN PHARMACEUTICALS ?

The latest Fixed Capital/Sales ratio of LINCOLN PHARMACEUTICALS is 0.38 based on Mar2026 Consolidated results.
Year Fixed Capital/Sales
Mar20260.38
Mar20250.37
Mar20240.36
Mar20230.34
Mar20220.32

How is Fixed Capital/Sales of LINCOLN PHARMACEUTICALS Trending?

Years Fixed Capital/Sales % Change
Mar2026 0.38
2.70
Mar2025 0.37
2.78
Mar2024 0.36
5.88
Mar2023 0.34
6.25
Mar2022 0.32 -

Other Financial Ratios of LINCOLN PHARMACEUTICALS


Compare Fixed Capital/Sales ratio of peers of LINCOLN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS ₹1,164.3 Cr -1.4% -4.7% 7.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹434,280.0 Cr -2.4% -6.2% 11.8% Stock Analytics
DIVIS LABORATORIES ₹246,737.0 Cr -3.3% 1.4% 57.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹181,129.0 Cr -4.5% -4% 35.9% Stock Analytics
CIPLA ₹108,808.0 Cr -3.6% -5% -10.6% Stock Analytics
DR REDDYS LABORATORIES ₹100,170.0 Cr -0.2% 2.5% -3% Stock Analytics


LINCOLN PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS

-1.4%

-4.7%

7.7%

SENSEX

-2.3%

-6.6%

-12%


You may also like the below Video Courses